These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 14613957)

  • 1. Outer membrane protein alterations and blaTEM-1 variants: their role in beta-lactam resistance in Klebsiella pneumoniae.
    Nelson EC; Segal H; Elisha BG
    J Antimicrob Chemother; 2003 Dec; 52(6):899-903. PubMed ID: 14613957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo selection of OmpK35-deficient mutant after cefuroxime therapy for primary liver abscess caused by Klebsiella pneumoniae.
    Lee CH; Chia JH; Chu C; Wu TL; Liu JW; Su LH
    J Antimicrob Chemother; 2006 Oct; 58(4):857-60. PubMed ID: 16880175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results.
    Carvalhaes CG; Picão RC; Nicoletti AG; Xavier DE; Gales AC
    J Antimicrob Chemother; 2010 Feb; 65(2):249-51. PubMed ID: 19996141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels.
    Källman O; Motakefi A; Wretlind B; Kalin M; Olsson-Liljequist B; Giske CG
    J Antimicrob Chemother; 2008 Nov; 62(5):986-90. PubMed ID: 18647746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.
    Leavitt A; Chmelnitsky I; Ofek I; Carmeli Y; Navon-Venezia S
    J Antimicrob Chemother; 2010 Feb; 65(2):243-8. PubMed ID: 19939824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.
    Loli A; Tzouvelekis LS; Tzelepi E; Carattoli A; Vatopoulos AC; Tassios PT; Miriagou V
    J Antimicrob Chemother; 2006 Sep; 58(3):669-72. PubMed ID: 16870645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy.
    Findlay J; Hamouda A; Dancer SJ; Amyes SG
    Clin Microbiol Infect; 2012 Feb; 18(2):140-6. PubMed ID: 21745255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum beta-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina.
    Melano R; Corso A; Petroni A; Centrón D; Orman B; Pereyra A; Moreno N; Galas M
    J Antimicrob Chemother; 2003 Jul; 52(1):36-42. PubMed ID: 12775675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
    Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
    Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss.
    Lee K; Yong D; Choi YS; Yum JH; Kim JM; Woodford N; Livermore DM; Chong Y
    Int J Antimicrob Agents; 2007 Feb; 29(2):201-6. PubMed ID: 17204406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.
    Woodford N; Tierno PM; Young K; Tysall L; Palepou MF; Ward E; Painter RE; Suber DF; Shungu D; Silver LL; Inglima K; Kornblum J; Livermore DM
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4793-9. PubMed ID: 15561858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
    Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
    Shi W; Li K; Ji Y; Jiang Q; Wang Y; Shi M; Mi Z
    Braz J Microbiol; 2013; 44(2):435-42. PubMed ID: 24294234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital.
    Chudácková E; Bergerová T; Fajfrlík K; Cervená D; Urbásková P; Empel J; Gniadkowski M; Hrabák J
    FEMS Microbiol Lett; 2010 Aug; 309(1):62-70. PubMed ID: 20528936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC beta-lactamases.
    Essack SY; Hall LM; Livermore DM
    Int J Antimicrob Agents; 2004 Apr; 23(4):398-400. PubMed ID: 15081091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
    J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.